Filter
318
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
35
New Publications
64
Language
Document type
No document type
128
Studies & Reports
78
Guidelines
63
Manuals
18
Strategic & Response Plan
17
Fact sheets
5
Training Material
3
Situation Updates
2
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
Global
18
Western and Central Europe
12
India
10
Kenya
9
Ethiopia
8
Nigeria
6
Ghana
5
Philippines
5
Rwanda
5
South Africa
5
Malawi
5
Eastern Europe
5
Senegal
4
Uganda
4
Zimbabwe
4
Nepal
3
Syria
3
Tanzania
3
Namibia
3
Ukraine
3
South–East Asia Region
3
Sudan
2
Botswana
2
West and Central Africa
2
Africa
2
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
Mali
1
Pakistan
1
South Sudan
1
Zambia
1
Egypt
1
Cambodia
1
Thailand
1
China
1
Indonesia
1
Bangladesh
1
Eswatini/ Swaziland
1
North Macedonia
1
Serbia
1
Chile
1
East and Southern Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Latin America and the Carribbean
1
Eastern Europe and Central Asia
1
Asia
1
Albania
1
Timor Leste/ East Timor
1
Russia
1
Iran
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
96
Clinical Guidelines
27
Key Resources
21
Public Health
17
Pharmacy & Technologies
13
Women & Child Health
12
Capacity Building
3
Toolboxes
AMR
42
Pharmacy
39
COVID-19
29
HIV
19
TB
18
Rapid Response
13
Mental Health
12
NTDs
8
NCDs
8
Conflict
7
Caregiver
7
Planetary Health
7
Global Health Education
6
Disability
4
Health Financing Toolbox
4
2.0 Rapid Response
4
Specific Hazards
3
Ebola & Marburg
2
Polio
2
Refugee
2
Zika
2
Malaria
2
Natural Hazards
1
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
Revised Edition
The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.
The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect popul
...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt
...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea
...
The 2023 meeting of the WHO Clinical Consortium on Healthy Ageing (CCHA) was the group’s ninth gathering and took place in Geneva 5–7 December 2023. The meeting was structured around seven panels, with a series of technical presentations, plenary discussions and group work, and a final session o
...
The aim of these Guidelines is to provide a framework for the conservation and sustainable use of plants in medicine. To do this, the Guidelines describe the various tasks that should be carried out to ensure that where medicinal plants are taken from the wild, they are taken on a basis that is sust
...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has
...
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults,
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
PLoS Negl Trop Dis 14(1): e0007999. January 30, 2020 is the first-ever World Neglected Tropical Diseases Day (World NTD Day), a day when we celebrate the achievements made towards control of the world’s NTDs, yet recognize the daunting challenges we face in the control and elimination of these con
...
This research paper uses the Health Resources and services Availability Mapping System (HeRAMS) database to develop two composite indices – one for health centres and one for hospitals – in order to analyse and assess the health facilities’ performance across time and to evaluate the di
...
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly
...
The Interagency Emergency Health Kit 2017
recommended
Interagency Guidelines; Medicines and medical devices for 10 000 people for approximately three month.
Drinking-water quality regulations and standards developed or revised in accordance with this guidance will reflect the best practices identified in the WHO Guidelines for Drinking-water Quality to most effectively protect public health. Moreover, the regulations and standards will consider local ne
...
Fourth Edition
Über SARS-CoV-2-Testsysteme informieren das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) und das Paul-Ehrlich-Institut. Die Informationen ergänzen sich, den rechtlichen Rahmen bietet u.a. die Coronavirus-Testverordnung-TestV.
Das BfArM bietet eine Liste von Antigen-Tests zum dir
...
